Lazard Asset Management LLC Buys 243,054 Shares of BlackRock Health Sciences Term Trust $BMEZ

Lazard Asset Management LLC lifted its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 64.2% during the first quarter, HoldingsChannel reports. The institutional investor owned 621,604 shares of the company’s stock after purchasing an additional 243,054 shares during the period. Lazard Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $8,926,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of BMEZ. Quantedge Capital Pte Ltd lifted its stake in BlackRock Health Sciences Term Trust by 85.0% in the 1st quarter. Quantedge Capital Pte Ltd now owns 135,854 shares of the company’s stock worth $1,951,000 after purchasing an additional 62,400 shares in the last quarter. PNC Financial Services Group Inc. bought a new position in shares of BlackRock Health Sciences Term Trust in the first quarter worth $35,000. SouthState Bank Corp bought a new position in shares of BlackRock Health Sciences Term Trust in the first quarter worth $29,000. Calamos Advisors LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the first quarter worth $740,000. Finally, NWF Advisory Services Inc. raised its position in shares of BlackRock Health Sciences Term Trust by 16.7% in the first quarter. NWF Advisory Services Inc. now owns 40,469 shares of the company’s stock worth $581,000 after buying an additional 5,784 shares in the last quarter.

BlackRock Health Sciences Term Trust Stock Performance

BlackRock Health Sciences Term Trust stock opened at $15.48 on Thursday. BlackRock Health Sciences Term Trust has a 52 week low of $13.67 and a 52 week high of $15.80. The business has a 50-day simple moving average of $14.91 and a 200 day simple moving average of $14.73.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.11 per share. This represents a c) dividend on an annualized basis and a dividend yield of 8.5%. The ex-dividend date is Tuesday, September 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.